| Sr. No. | Title |
|---|---|
| 1 |
A flow cytometry assay and rapid agglutination test for the detection of anti-FVIII antibodies- SERB PI: Dr. Rucha Patil |
| 2 |
Antibody Profile in post- vaccinated individuals when compared to post-COVID-19 patients PI: Dr. Rucha Patil |
| 3 |
Clinical, Immunological and Molecular characterization of an Autoimmune Lymphoproliferative Syndrome (ALPS) and B-cell expansion with NF?? and T- cell anergy(BENTA) in Indian population. PI: Dr. Manisha Madkaikar |
| 4 |
Clinical, Molecular and Cytogenetic Study of Myeloproliferative neoplasms PI: Dr. Babu Rao Vundinti |
| 5 |
Comprehensive immune profiling and its correlation with response to therapy and underlying genetic variations in Immune Thrombocytopenia (ITP). PI: Dr. Manisha Madkaikar |
| 6 |
Defining immunological markers for response to therapy in Aplastic Anemia PI: Dr. Manisha Madkaikar |
| 7 |
Development of G6PD point of care test (ICMR) PI: Dr. Rucha Patil |
| 8 |
Exploring immune players in clinical conditions of HBV infection. PI: Dr. Anindita Banerjee |
| 9 |
Exploring lymphocyte subsets and cytokine profile in Pediatric Inflammatory Multisystem Syndrome temporally related to SARS-CoV-2 infection (PIMS-TS). (Intramural) PI: Dr. Manisha Madkaikar |
| 10 |
ICMR Task force study on Rational Use of Medicines PI: Dr. Manisha Madkaikar |
| 11 |
Identification and molecular characterization of weak D variants among apparently RhD negative individuals from South India (Intramural project in collaboration with JIPMER) PI: Dr Swati Kulkarni |
| 12 |
Immune response to precautionary third dose of COVISHIELD/COVAXIN among healthy adult population: an ICMR Cohort study, India PI: Dr. Reetika Yadav |
| 13 |
Molecular studies of Keap1-Nrf2 signalling axis in the pathophysiology of Sickle cell disease: an exploratory study PI: Dr. Naga Merugu |
| 14 |
Multi Centric Collaborative Study of the National Registry for Rare Disorders in India- Bleeding disorders PI: Dr. Rucha Patil |
| 15 |
Platelet phenotyping (surface receptors, granules, secretion, and signal transduction) and genotyping of unclassified heritable thrombocytopenia and platelet function disorders. PI: Dr. Bipin Kulkarni |
